MedTrace Logo

Assessment of Efficacy of Vardenafil in Subjects With Erectile Dysfunction and Diabetes, Hypertension or Hyperlipidemia

NCT00668109 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 614

Last updated 2014-12-23

No results posted yet for this study

Summary

Assessment of efficacy of vardenafil in subjects with erectile dysfunction and diabetes, hypertension or hyperlipidemia

Conditions

Interventions

DRUG

Levitra (Vardenafil, BAY38-9456)

10 mg one hour prior to sexual intercourse

DRUG

Tadalafil

10 mg taken approximately 24 hours prior to sexual intercourse

Sponsors & Collaborators

Principal Investigators

  • Bayer Study Director · Bayer

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-12-31
Primary Completion
2004-06-30
Completion
2004-06-30

Countries

  • Belgium
  • Colombia
  • Finland
  • Germany
  • Israel
  • Italy
  • Mexico
  • Netherlands
  • Norway
  • Peru
  • South Africa
  • Spain
  • Sweden

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00668109 on ClinicalTrials.gov